Intervention

Polygenic Risk Score

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions4

Lead sponsors shown2

Clinical trials

3 shown

Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 DiabetesNCT06586203 · 2024-08-23

Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 StudyNCT04474834 · 2019-10-17

ACTIVE_NOT_RECRUITING

Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication UptakeNCT02517593 · 2016-03-01

Common conditions

Breast Cancer2 Cardiovascular Diseases1 Diabetes Mellitus, Type 21 Diabetic Nephropathy Type 21

Leading sponsors

Mayo Clinic2 Optithera1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

RECRUITING1

Phase mix

NA1

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.